XLV

7 American ETFs for the Hometown Crowd

By Todd Shriber, InvestorPlace Contributor
American ETFs stocks are again outpacing their international rivals, giving some credibility to having a home country bias.

3 Healthcare Stocks Popping Off Support

By Tyler Craig, Tales of a Technician
Healthcare stocks are pulling the market higher today. Here are three of the best stocks to buy in the sector right now.

7 of the Best Healthcare ETFs to Purchase for 2020

By Todd Shriber, InvestorPlace Contributor
Don't ignore healthcare stocks because 2020 is an election year. Some of these funds are poised for big upside.

Apellis is Outperforming the Pharmaceutical Sector

By Ken Trester
This week I want to take a bullish position in the underperforming pharmaceutical sector with Apellis Pharmaceuticals, Inc. (NASDAQ:APLS).

Finding Predictability Amid the Uncertainty on Wall Street

By John Jagerson and Wade Hansen
Looking at which sectors in the S&P 500 are outperforming and the broader market right now shows us that we are in a normal contraction.

Use Johnson & Johnson for Quick Income

By Ken Trester
Traders need to be selective with their options, and Johnson & Johnson (NYSE:JNJ) has proven itself resilient.

Healthcare Stocks Aren’t Immune to Selloffs

By Ken Trester
Guardant Health, Inc. (NASDAQ:GH) is a healthcare stock, but it operates in the wrong segment.

7 of the Best Healthcare ETFs to Purchase for 2020

By Todd Shriber, InvestorPlace Contributor
Don't ignore healthcare stocks because 2020 is an election year. Some of these funds are poised for big upside.

Use This Healthcare ETF to Prepare for a Pullback

By Ken Trester
This morning, I'm recommending a bearish trade on the Health Care Select Sector SPDR Fund (NYSEARCA:XLV).

Stock Market Bears Are Starting to Hibernate

By John Jagerson and Wade Hansen
As winter comes, bears are hibernating, giving way to a bull market. Want some evidence? Just look at the performance of small-cap stocks.

Buy This If You Like Johnson & Johnson Stock But Hate the Lawsuits  

By Will Ashworth, InvestorPlace Contributor
The recent ruling against Johnson & Johnson (NYSE:JNJ) put some pressure on JNJ stock. Here’s a good way to prevent huge losses.   

HCP, Inc. is a Way to Play Real Estate and Healthcare

By Ken Trester
I want to avoid recommending too many bearish trades while we wait for the market to recover. That's why I'm recommending a bullish trade on HCP, Inc. (NYSE:HCP), a real estate investment trusts (REIT) that serves the healthcare industry.

7 SPDR ETFs and What They Tell Us About the Market

By Mark Putrino, CMT
Two weeks ago these SPDR ETFs told me that the rally was over. This is what they are telling me now. There are reasons to be bearish.

Johnson & Johnson Could Turn Around After its Strong Earnings

By Ken Trester
After its last earnings report, Johnson & Johnson (NYSE:JNJ) looks like a good target for a cheap ratio call debit spread.

7 Great Sector ETFs to Buy for the Short or Long Term

By Todd Shriber, InvestorPlace Contributor
Sector ETFs are useful for both short-term traders looking to capitalize on events or long-term investors after stability from a longer trend.

Kidney Dialysis Stocks are a Profitable Healthcare Bet

By Ken Trester
This morning, I am recommending a bullish trade on Baxter International Inc. (NYSE:BAX),  the renal and hospital product provider.

These 6 SPDR ETFs and Amazon Tell Me the Rally Is Over

By Mark Putrino, CMT
To understand market moves, you need to understand what the underlying sectors are doing. These 6 SPDR ETFs and Amazon say the rally is over.

This Medical Device Company is Outperforming the Rest of the Sector

By Ken Trester
This morning, I am recommending a bullish trade on Repligen Corporation (NASDAQ:RGEN), the bioprocessing company.

Two Healthcare Stocks in the XLV Fund Stand Out

By Luce Emerson, InvestorPlace Contributor
MRK stock and ABBV stock are promising healthcare stocks to invest in from the XLV fund. MRK is 6% of holdings and AbbVie makes up 3.5%.
Load More